試す - 無料

A Vaccine for all Occasions

Newsweek

|

May 21 - 28, 2021 (Double Issue)

Scientists are developing a “universal vaccine” that would protect against anything the coronavirus can throw at us and maybe even the common cold.

- By Adam Piore

A Vaccine for all Occasions

It took Barney Graham, Jason Mclellan and their collaborators just a weekend in January 2020 to design a novel vaccine they believed would be capable of protecting people against COVID-19. Their design formed the basis for the vaccines that Moderna, Pfizer and others would eventually use to inoculate millions of Americans a little more than a year later, a pace of development unprecedented in the annals of modern medicine.

By then, however, the two pioneering virologists were already thinking about future pandemics— and how they might get ahead of them.

Graham and McLellan are part of a corps of researchers hoping to take the technology they used on COVID-19 vaccines and apply them to an even more futuristic creation: an arsenal of off-the-shelf premade vaccines that could be easily modified to attack new pathogens as they arise—a kind of “pan” or “universal” coronavirus vaccine capable of protecting against many different strains of the virus at the same time.

Even as scientists race to develop booster shots and tweak existing vaccines to work against new variants to SARS2, they’re looking ahead to future pandemics caused by entirely new pathogens from the same coronavirus family, one of just 26 known to infect humans. But SARS-CoV-2 is the third novel, deadly coronavirus to cross over from animals to humans in the last 20 years, and many scientists warn more will inevitably follow. Even though a “universal” vaccine that can protect against any new coronavirus that nature throws at us probably won’t be available this year or next, development has become a high priority.

Newsweek からのその他のストーリー

Newsweek US

Newsweek US

TURN THESE PAGES

The best books Newsweek staffers read last year

time to read

8 mins

January 2, 2026

Newsweek US

Newsweek US

CHERYL HINES

The actor discusses her new memoir Unscripted, her Hollywood roots and life with husband Robert F. Kennedy Jr. inside the Trump administration

time to read

2 mins

January 2, 2026

Newsweek US

Newsweek US

THE MIDDLE CLASS FLORIDA DREAM IS OVER

Higher housing costs are pushing a life in the Sunshine State out of reach for many Americans

time to read

11 mins

January 2, 2026

Newsweek US

Newsweek US

MIND GAMES

Mentalist Oz Pearlman on using storytelling to read his audience and the secret to sticking to New Year's resolutions

time to read

6 mins

January 2, 2026

Newsweek US

Newsweek US

DACRE MONTGOMERY

DACRE MONTGOMERY HAS HAD A LOT OF PINCH-ME MOMENTS IN THE PAST few years.

time to read

1 mins

January 2, 2026

Newsweek US

Newsweek US

GEN Z IS LIT

Images of celebrities smoking have become popular on social media among young people, despite the generation's clean-living image

time to read

4 mins

January 2, 2026

Newsweek US

Newsweek US

AMERICA'S BEST REGIONAL BANKS & CREDIT UNIONS 2026

These financial institutions are ones you can trust for your business and personal banking relationshipswithout the corporate feel

time to read

4 mins

January 2, 2026

Newsweek US

Newsweek US

Complete Control

Kate Winslet has been a screen icon for three decades. Now she's stepped behind the camera to direct her first feature film

time to read

8 mins

January 2, 2026

Newsweek US

Newsweek US

From the Arctic to the Sahara, Extremes Put New Vehicles to the Test

BATTLE TESTED Mercedes-Benz GLB undergoes extreme conditions testing in Germany.

time to read

1 mins

December 26, 2025

Newsweek US

Newsweek US

'IF HE GETS RID OF MADURO, WE'LL FORGIVE HIM'

Venezuelan exiles in a Miami suburb are backing Trump's efforts to remove the leader from power

time to read

4 mins

December 26, 2025

Translate

Share

-
+

Change font size